These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 8748063)

  • 81. Is there a future for neuropeptide receptor ligands in the treatment of anxiety disorders?
    Griebel G
    Pharmacol Ther; 1999 Apr; 82(1):1-61. PubMed ID: 10341356
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Evidence for a functional role of cholecystokinin receptors in the rat thyroid gland.
    Ginda WJ
    Folia Histochem Cytobiol; 2001; 39(4):331-4. PubMed ID: 11766768
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Role of cholecystokinin in the control of food intake.
    Peikin SR
    Gastroenterol Clin North Am; 1989 Dec; 18(4):757-75. PubMed ID: 2693351
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Antipsychotic potential of CCK-based treatments: an assessment using the prepulse inhibition model of psychosis.
    Feifel D; Reza T; Robeck S
    Neuropsychopharmacology; 1999 Feb; 20(2):141-9. PubMed ID: 9885794
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Mediation by CCKB receptors of the CCK-evoked hyperaemia in rat gastric mucosa.
    Heinemann A; Jocic M; Holzer-Petsche U; Pethö G; Peskar BM; Horwell DC; Holzer P
    Br J Pharmacol; 1995 Oct; 116(4):2274-8. PubMed ID: 8564259
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Selective activation of CCK-B receptors does not induce sleep and does not affect EEG slow-wave activity and brain temperature in rats.
    Chang HY; Kapás L
    Physiol Behav; 1997 Jul; 62(1):175-9. PubMed ID: 9226359
    [TBL] [Abstract][Full Text] [Related]  

  • 87. [Cholecystokinin and cholecystokinin receptor].
    Funakoshi A
    Nihon Rinsho; 1996 Apr; 54(4):1097-1103. PubMed ID: 8920681
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Receptor mediation of the stimulus properties of cholecystokinin.
    Melton PM; Riley AL
    Pharmacol Biochem Behav; 1994 May; 48(1):275-9. PubMed ID: 8029299
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Effects of cholecystokinin and cholinergic receptor blockade on guinea pig pepsinogen secretion.
    Basson MD; Adrian TE; Modlin IM
    Scand J Gastroenterol; 1990 Aug; 25(8):825-33. PubMed ID: 2402588
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Cholecystokinin-dopamine receptor interactions as studied with cholecystokinin receptor antagonists.
    Murphy RB
    Prog Clin Biol Res; 1985; 192():105-13. PubMed ID: 3001746
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Biology of gut cholecystokinin and gastrin receptors.
    Shulkes A; Baldwin GS
    Clin Exp Pharmacol Physiol; 1997; 24(3-4):209-16. PubMed ID: 9131287
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Systemic administration of cholecystokinin (CCK) inhibits operant water intake in rats: implications for the CCK-satiety hypothesis.
    Ebenezer IS
    Proc Biol Sci; 1996 Apr; 263(1369):491-6. PubMed ID: 8637930
    [TBL] [Abstract][Full Text] [Related]  

  • 93. From gut nutrient sensing to nutrient perception: a cooperative role involving CCK and 5-HT?
    Tomé D
    Am J Physiol Regul Integr Comp Physiol; 2007 Mar; 292(3):R1061-2. PubMed ID: 17158260
    [No Abstract]   [Full Text] [Related]  

  • 94. Cholecystokinin as a target for neuropsychiatric drugs.
    Bourin M
    Drug News Perspect; 1998 Aug; 11(6):342-9. PubMed ID: 15616622
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Case of Peculiar Nervous Excitement.
    Asbury JV
    Lond Med Phys J; 1826 Jan; 55(323):16-17. PubMed ID: 30494916
    [No Abstract]   [Full Text] [Related]  

  • 96. Cholecystokinin-Mediated Neuromodulation of Anxiety and Schizophrenia: A "Dimmer-Switch" Hypothesis.
    Ballaz SJ; Bourin M
    Curr Neuropharmacol; 2021; 19(7):925-938. PubMed ID: 33185164
    [TBL] [Abstract][Full Text] [Related]  

  • 97. The CCK-system underpins novelty-seeking behavior in the rat: gene expression and pharmacological analyses.
    Ballaz SJ; Akil H; Watson SJ
    Neuropeptides; 2008 Jun; 42(3):245-53. PubMed ID: 18410964
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Identification of cell-type-specific promoters within the brain using lentiviral vectors.
    Chhatwal JP; Hammack SE; Jasnow AM; Rainnie DG; Ressler KJ
    Gene Ther; 2007 Apr; 14(7):575-83. PubMed ID: 17235291
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Cholecystokinin in psychiatric research: a time for cautious excitement.
    Abelson JL
    J Psychiatr Res; 1995; 29(5):389-96. PubMed ID: 8748063
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Neuropeptides and anxiety: focus on cholecystokinin.
    Lydiard RB
    Clin Chem; 1994 Feb; 40(2):315-8. PubMed ID: 8313613
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.